Indivumed Therapeutics is a global oncology company, with a focus on bioinformatics and multi-omics-based oncology R&D. Utilizing the same high-quality multi-omics and clinical datasets all the way through, we use AI-assisted advanced analytics to drive biomarker discovery as well as novel target identification and validation for potential therapies.
Get a brief overview of our work and what we have in store for you at ESMO.
Join our Poster Presentation
Combining Cancer Patient Spatial Transcriptomics and bulk RNA-Seq data to drive insights into NSCLC
October 21, 2023, 12 – 1 pm, Hall 8 Poster Area
Contacts and Appointments
Click this link to get in touch with our team
From Sample to Drug Deep Dive
Learn more about our holistic workflow